A Study to Evaluate Efficacy and Safety of MK-7240 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

Condition:   Ulcerative Colitis Interventions:   Drug: IV MK-7240;   Drug: IV Placebo;   Drug: SC MK-7240;   Drug: SC Placebo Sponsors:   Merck Sharp & Dohme LLC;   PPD, Part of Thermo Fisher Scientific Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials